company mission
Ichor's core mission looks stable across these two snapshots. In January 2022 and February 2023, it says the same basic thing: the company exists to help people live longer, healthier lives by serving biotech and pharma clients through lab research services. That is not a pivot. It is continuity. What changes is the framing around the service model. The 2022 language leans on identity and posture: premium service, high quality, unconventional thinking, a belief that strong scientific execution can help change the world. By 2023, the pitch is more operational. Ichor stresses that it is a hands-on development partner, says it is more than a standard CRO, and adds concrete process claims like reproducibility, robust methods, and objective-oriented problem solving. That shift matters, but only a little. The company still ties its purpose to longer, healthier lives and still sells itself on scientific rigor plus unusual thinking. The newer wording narrows the claim from broad aspiration toward execution and program advancement. In plain terms, the mission stays put; the sales pitch gets sharper. Evidence is thin because we only have two website snapshots about a year apart, and both are polished self-description. We can say the messaging became more explicit about partner-style development work. We cannot say the underlying business or scientific direction changed in a major way from this alone.